Indiana doctor: Covid-19 vaccines are attacking the nervous system, causing multiple sclerosis-like illness

After seeing what the vaccines had done to his patients, a board-certified neurologist decided NOT to get a Covid vaccine and sought an exemption from his employer

In February, a neurologist in Indiana testified before a state Senate committee, and what he said was alarming.

His testimony has never been shared with the general public.

Matt Bain, a board-certified neurologist, said that although he initially believed the mRNA vaccines would be the “silver bullet” that would end the pandemic, he soon saw that they were causing neurological harm to many people as patients began to flood his office with serious ailments, including Guillain-Barre syndrome, a condition similar to multiple sclerosis, and transverse myelitis — inflammation of the spinal cord.

“In January 2021, I treated a previously healthy patient who developed symptoms consistent with acute transverse myelitis within 72 hours of receiving her first Pfizer injection,” said Bain. “I've since treated three additional patients with transverse myelitis with no better explanation than a recent SARS-CoV-2 vaccination.”

He also said he’d treated several patients who’d had strokes, although they had no known risk factors.

Bain was testifying before the Indiana Senate Committee on Health and Provider Services on H.B. 1001 — a bill meant to secure exemptions for employees of corporations in the state who were mandating the vaccine.

Nurses with one Indiana hospital in particular had testified at a hearing three months earlier that they were about to lose their jobs after their requests for religious exemptions were summarily denied.

At the start of the February hearing, Sen. Mark Messmer (R-Bedford) announced an amendment to the bill that would take out all protections for healthcare workers; allow sports venues and entertainment complexes in the state to deny exemptions to their vaccine mandates and allow corporations to require twice-a-week testing for employees with exemptions.

Most of those who testified in opposition said they’d come to support the bill, but now wanted senators to vote NO because of the Messmer amendment.

Dr. Matt Bain was one of them.

“I, as many others here, had come intending to support House Bill 1001 As it stands without being amended,” he said. “As the amendment has passed, I can no longer provide my support for the bill.”

He went on to introduce himself and outline his qualifications.

“My name is Matt Bain. I'm a Christian. I'm a board-certified general neurologist. Apart from the four years I spent in Arkansas during elementary school, I’m a lifelong Hoosier. I graduated medical school and completed my neurology residency here at IU [Indiana University]. Last month I completed my 17th year in practice as a general neurologist. I'm 100 percent clinical, and I spend all my professional time caring directly and indirectly for my patients. I don't devote any time to research and I work in a busy referral hospital.”

Bain says he followed the news of the pandemic and closely followed news of the development of the new vaccines.

“Like so many of us, I vividly remember watching the case numbers of this new virus start to accumulate in March 2020 as if it was some sort of a deadly draft creeping across our state. The clinic closed and virtual visits ensued and became standard. We tried to figure out how to interact with patients with limited personal protective equipment in the hospital. I unleashed the obsessive-compulsive trait that served me so well in medical school by continuing to try to wipe down all the groceries when I came home with antibacterial wipes. I slept in my basement for four months, and I tried to isolate myself from my family. Surely the only way back to normal was for someone to develop a vaccine.”

He said he was sure that the vaccines would bring an end to the pandemic and allow Americans to return to their normal lives, and was so enthusiastic about the new vaccines that he signed up to participate as a volunteer in the AstraZeneca trial.

“In the fall of 2020, I registered for the AstraZeneca trial that was to be held here in Indianapolis. Before I could receive the injection, the trial was held for several weeks due to a new diagnosis of multiple sclerosis and two cases of transverse myelitis, which is acute inflammation of the spinal cord, in the study group. Both of these diseases I treat regularly.”

Still, he says he thought that vaccines were the answer.

“I thought surely the novel mRNA technology would be a silver bullet to end the pandemic. A flurry of cases of Bell's Palsy, which is [inaudible] facial paralysis, were identified early following the rollout of the Pfizer injection and were dismissed as nothing more than sporadic. Was there somehow some affinity of these vaccines for the nervous system? That's not uncommon. As we expect, one case per million in flu vaccinations result in a disease called Guillain-Barre syndrome each year, which is an ascending paralysis that can often result in the need for mechanical ventilation for life support.”

Then he began to talk about what he was seeing in the patients he was treating in the clinic where he works in Indiana.

“In January 2021, I treated a previously healthy patient who developed symptoms consistent with acute transverse myelitis within 72 hours of receiving her first Pfizer injection. I've since treated three additional patients with transverse myelitis with no better explanation than a recent SARS-CoV-2 vaccination.”

He went on to tell senators of other ailments he has been seeing in patients who’ve had the vaccine.

“Additionally, I've treated two patients with ADEM, which is a condition similar to multiple sclerosis, and which can lead to that diagnosis in 15 to 20 percent of the cases chronically; several strokes in patients with no known risk factors; three cases of Guillain-Barre syndrome, one case of [inaudible] fulminant multiple sclerosis; one case of brachial plexitis from herpes zoster, one case of primary central nervous system lymphoma; several cases of peripheral polyneuropathy; one new diagnosis of myasthenia gravis and multiple instances of peripheral polyneuropathy in addition to worsening migraine headaches in several patients with no better explanation than recent SARS-CoV-2 vaccination.”

He said he started looking in VAERS, the Vaccine Adverse Event Reporting System, and saw that there were many cases like these.

“Each of these diagnoses has a strong signal in the Vaccine Adverse Event Reporting System [VAERS] which has continued to climb since I regularly began following the numbers in the spring of 2021. As of this week, 56 cases of ADEM; 7,771 strokes; 883 cases of Guillain-Barre syndrome; 1,625 cases of multiple sclerosis; 29 cases of central nervous system lymphoma; 3,136 cases of peripheral neuropathy and 264 cases of myasthenia gravis have been reported to the VAERS system following vaccination with each of the three SARS-CoV-2 vaccinations available in the U.S. Each of these numbers represents a patient whose life has changed and I have personally treated some of them and know them by name.”

He went on to tell senators of the sharp increases in these neurological conditions since the Covid-19 vaccines were introduced.

“For context, in the case of transverse myelitis, the American Academy of Neurology published an article in 2017 which looked at the incidence of transverse myelitis following all vaccinations administered in the United States between 1985 and 2017 and found 119 cases — 292 cases have now been reported among the three SARS-Cov-2 vaccines given in the U.S. over the past 13 months. This has increased from 139 cases in June 2021. The incidence of Guillain-Barre Syndrome among the same three vaccinations is roughly four times that expected from the annual flu vaccine. I'm quite certain that these numbers are underestimated. In my own experience, only a handful of patients’ charts have made reference to a patient’s SARS-CoV-2 vaccination status and timing when presenting with acute neurologic illness.”

He said he wanted to be clear that he’d also treated some of these ailments in patients with Covid-19.

“I've also seen this [inaudible] of long haul Covid. I do not discount the impact of this infection on the central nervous system in particular. [But] as a neurologist who has treated multiple patients with neurologic adverse events following vaccination against SARS-Cov-2, I have a particular uneasiness when I hear the phrase “safe and effective” when used in the context of these vaccines. I’m fortunate that my employer has recognized my conviction not to receive one of these vaccinations and has granted me a religious exemption. Countless others have been far less fortunate. My role as a physician is not to make decisions for my patients, but rather to inform them of the risks inherent to whatever treatment they may or may not choose to pursue. Therein lies the beauty of the relationship. I provide transparency without coercion, and the patient makes his or her independent choice through proactive engagement. Mr. Chairman, I give you my word that I will offer you the same objectivity and transparency if you were ever my patient. I support the right of those who have chosen to receive these vaccinations. I simply ask that you protect the livelihoods of those who choose not to receive them.”

Following the conclusion of the hearing, the committee voted to amend the bill and send it to the full Senate. All Republicans on the committee voted “yes” while all the Democrats voted “no.”

The bill was subsequently passed and signed into law by Gov. Eric Holcomb.

The full hearing can be viewed by clicking HERE and going to the Feb. 16 hearing in the drop-down menu.